Pyrrolo[3,4-d]pyrimidines as corticotropin releasing factor (CRF) antagonists

摘要

Corticotropin releasing factor (CRF) antagonists of Formula (II)and their use in treating anxiety, depression, and other psychiatric, neurological disorders as well as treatment of immunological, cardiovascular or heart-related diseases and colonic hypersensitivity associated with psychopathological disturbance and stress.